SCHEMBL22361415

SCHEMBL22361415

CCCC(C)(CC)C(=O)[C@H](Cc1cnn[nH]1)NC(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10120407 0.85 MME (0.31) —
SCHEMBL14886286 0.78 MME (0.31) —
SCHEMBL14864778 0.78 MME (0.32) —
SCHEMBL14850463 0.78 MME (0.32) —
SCHEMBL888696 0.76 ACACB (0.33) —
SCHEMBL10122822 0.76 ACACB (0.33) —
SCHEMBL8911903 0.76 ACACB (0.33) —
SCHEMBL19578425 0.75 CTSK (0.36) —
SCHEMBL19578484 0.73 CTSK (0.33) —
SCHEMBL19578342 0.68 TSHR (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10752611-B2 Benzimidazole derivatives ENANTA PHARMACEUTICALS, INC. (US) 2020-08-25 — — US disclosed
Send feedback